$3.39
-0.05 (-1.45%)
Open$3.44
Previous Close$3.44
Day High$3.47
Day Low$3.34
52W High$7.34
52W Low$1.38
Volume—
Avg Volume594.8K
Market Cap130.18M
P/E Ratio—
EPS$-2.08
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,024.8% upside
Current
$3.39
$3.39
Target
$38.13
$38.13
$23.34
$38.13 avg
$40.06
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 169.99M | 241.22M | 22.23M |
| Net Income | -373,304,679 | -476,762,042 | -3,026,461 |
| Profit Margin | -219.6% | -208.6% | -13.6% |
| EBITDA | -172,933,843 | -233,130,624 | -4,014,681 |
| Free Cash Flow | — | — | -2,971,274 |
| Rev Growth | -29.5% | -29.5% | +14.5% |
| Debt/Equity | 0.41 | 0.41 | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |